Vaxart Market Cap

Vaxart has a market cap or net worth of $172.91 million as of March 6, 2026. Its market cap has increased by 42.90% in one year.

Market Cap

172.91M

Enterprise Value

164.88M

1-Year Change

42.90%

Ranking

#3948

Market Cap Chart

Since December 1, 1998, Vaxart's market cap has increased from $89.40M to $172.91M, an increase of 93.41%. That is a compound annual growth rate of 2.51%.

Market Cap History

Date	Market Cap	% Change
Jul 7, 2025	73.00M	-51.53%
Dec 31, 2024	150.60M	72.90%
Dec 29, 2023	87.10M	-30.93%
Dec 30, 2022	126.10M	-83.98%
Dec 31, 2021	786.90M	25.88%
Dec 31, 2020	625.10M	3,643.11%
Dec 31, 2019	16.70M	24.63%
Dec 31, 2018	13.40M	-38.81%
Dec 29, 2017	21.90M	-53.89%
Dec 30, 2016	47.50M	-36.67%
Dec 31, 2015	75.00M	-4.58%
Dec 31, 2014	78.60M	-33.84%
Dec 31, 2013	118.80M	531.91%
Dec 31, 2012	18.80M	-76.67%
Dec 30, 2011	80.60M	-67.21%
Dec 31, 2010	245.80M	-1.17%
Dec 31, 2009	248.70M	42.93%
Dec 31, 2008	174.00M	-21.20%
Dec 31, 2007	220.80M	-46.13%
Dec 29, 2006	409.90M	104.24%
Dec 30, 2005	200.70M	-76.55%
Dec 31, 2004	855.90M	44.31%
Dec 31, 2003	593.10M	147.13%
Dec 31, 2002	240.00M	-38.92%
Dec 31, 2001	392.90M	125.03%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Galectin Therapeutics	191.81M
Compugen	187.07M
SAB Biotherapeutics	185.19M
Tiziana Life Sciences	185.05M
Molecular Partners AG	184.33M
Sagimet Biosciences	182.77M
Canton Strategic Holdings	182.63M
Nkarta	182.55M

Market Cap Rankings